Fangzhou Inc.
Research Fangzhou Inc. (6086.HK) on Bullrun: market cap HKD 1.14B, P/E 82.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6086.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyHKD
- Market capHKD 1.14B
- P/E82.0
- Financial periodFY2025
- RevenueCNY 3.53B
- Revenue growth30.2%
- Net incomeCNY 11.83M
- Free cash flowCNY 67.24M
- Gross margin15.9%
Valuation Snapshot
latest market cap is HKD 1.14B; P/E is 82.0.
Peer valuation comparison
Latest P/E is 82x versus a Healthcare sector median of 21.69x (278.0% above).
Latest P/E is 82x versus a China median of 16.26x (404.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 3.53B | CNY 11.83M | CNY 67.24M | 15.9% | 0.01 | CNY 233.49M | CNY 35.79M | CNY 153.73M |
| FY2024 | CNY 2.71B | -CNY 854.89M | CNY 15.63M | 19.1% | -0.88 | CNY 174.64M | CNY 50.89M | CNY 131.70M |
| FY2023 | CNY 2.43B | -CNY 196.79M | CNY 16.63M | 20.0% | -0.15 | CNY 146.32M | CNY 49.72M | -CNY 1.90B |
| FY2022 | CNY 2.20B | -CNY 383.30M | -CNY 55.25M | 17.3% | -0.29 | CNY 134.91M | CNY 36.81M | -CNY 1.71B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.14B | 82.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Fangzhou Inc.
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory diseases.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Fangzhou Inc.'s market cap?
Fangzhou Inc.'s market capitalization is HKD 1.14B.
What is Fangzhou Inc.'s P/E ratio?
Fangzhou Inc.'s price-to-earnings (P/E) ratio is 82.0.
What does Fangzhou Inc. do?
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory diseases.